AIM Vaccine Co., Ltd. (HKG:6660)
Hong Kong · Delayed Price · Currency is HKD 1.795
+0.030 (1.70%)
Oct 9, 2026, 3:59 PM HKT
AIM Vaccine Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,002 | 1,166 | 1,285 | 1,187 | 1,264 | 1,570 | |
Revenue Growth | -20.66% | -9.29% | 8.22% | -6.06% | -19.49% | -4.14% |
Cost of Revenue | 336.91 | 405.47 | 331.52 | 1,799 | 236.41 | 275.43 |
Gross Profit | 664.74 | 760.2 | 953.51 | -611.21 | 1,028 | 1,295 |
Selling, General & Admin | 735.95 | 783.81 | 825.4 | 748.29 | 943.92 | 1,628 |
Research & Development | 132.31 | 191.28 | 363.13 | 636.4 | 500.31 | 307.35 |
Operating Expenses | 856.07 | 968.08 | 1,182 | 1,389 | 1,471 | 1,943 |
Operating Income | -191.34 | -207.87 | -228.76 | -2,000 | -443.79 | -648.73 |
Interest Expense | -59.96 | -57.84 | -60.8 | -43.83 | -25.69 | -10.7 |
Interest & Investment Income | 1.57 | 3.43 | 7.49 | 10.71 | 10.69 | 10.78 |
Currency Exchange Gain (Loss) | 5.37 | 2.67 | - | 0.66 | - | 2.03 |
Other Non Operating Income (Expenses) | 23.03 | 18.82 | 24.09 | 27.52 | 21.55 | 38.25 |
EBT Excluding Unusual Items | -221.32 | -240.79 | -257.97 | -2,005 | -437.24 | -608.38 |
Impairment of Goodwill | - | - | - | -211.44 | - | - |
Gain (Loss) on Sale of Investments | - | - | - | - | 3.07 | 1.67 |
Gain (Loss) on Sale of Assets | - | - | - | 6.92 | - | - |
Asset Writedown | -525.77 | -525.77 | -32.75 | -61.09 | - | - |
Pretax Income | -747.09 | -766.56 | -290.72 | -2,271 | -434.17 | -606.7 |
Income Tax Expense | -9.56 | -22.83 | -12.25 | -320.4 | -203.54 | 69.17 |
Earnings From Continuing Operations | -737.53 | -743.73 | -278.47 | -1,950 | -230.63 | -675.87 |
Minority Interest in Earnings | 70.37 | 68.27 | 1.24 | 649.24 | -88.97 | -16.9 |
Net Income | -667.17 | -675.46 | -277.23 | -1,301 | -319.6 | -692.77 |
Net Income to Common | -667.17 | -675.46 | -277.23 | -1,301 | -319.6 | -692.77 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 1,227 | 1,224 | 1,211 | 1,211 | 1,203 | 1,163 |
Shares Outstanding (Diluted) | 1,227 | 1,224 | 1,211 | 1,211 | 1,203 | 1,163 |
Shares Change | 0.86% | 1.05% | - | 0.71% | 3.44% | 20.78% |
EPS (Basic) | -0.54 | -0.55 | -0.23 | -1.07 | -0.27 | -0.60 |
EPS (Diluted) | -0.54 | -0.55 | -0.23 | -1.07 | -0.27 | -0.60 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 67.66 | -46.93 | -22.56 | -324.42 | -889.33 | -1,032 |
Free Cash Flow Per Share | 0.06 | -0.04 | -0.02 | -0.27 | -0.74 | -0.89 |
Gross Margin | 66.36% | 65.22% | 74.20% | -51.47% | 81.30% | 82.46% |
Operating Margin | -19.10% | -17.83% | -17.80% | -168.43% | -35.11% | -41.32% |
Profit Margin | -66.61% | -57.95% | -21.57% | -109.56% | -25.28% | -44.12% |
Free Cash Flow Margin | 6.75% | -4.03% | -1.75% | -27.32% | -70.35% | -65.73% |
EBITDA | -76.81 | -89.41 | -97.67 | -1,859 | -307.38 | -529.57 |
EBITDA Margin | -7.67% | -7.67% | -7.60% | -156.53% | -24.32% | -33.73% |
D&A For EBITDA | 114.53 | 118.46 | 131.09 | 141.38 | 136.41 | 119.16 |
EBIT | -191.34 | -207.87 | -228.76 | -2,000 | -443.79 | -648.73 |
EBIT Margin | -19.10% | -17.83% | -17.80% | -168.43% | -35.11% | -41.32% |